• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 117 -6 (80) 2025 - Khalimova Z.Y., Sabirov U.Y., Mirsaidova U.A. - ENDOCRINE DYSFUNCTIONS AND DERMATOLOGIC SIGNS: EPIDEMIOLOGY AND DIFFERENTIAL DIAGNOSIS

117 -6 (80) 2025 - Khalimova Z.Y., Sabirov U.Y., Mirsaidova U.A. - ENDOCRINE DYSFUNCTIONS AND DERMATOLOGIC SIGNS: EPIDEMIOLOGY AND DIFFERENTIAL DIAGNOSIS

ENDOCRINE DYSFUNCTIONS AND DERMATOLOGIC SIGNS: EPIDEMIOLOGY AND DIFFERENTIAL DIAGNOSIS

Khalimova Z.Y. - Republican Specialized Scientific and Practical Medical Center of Endocrinology named after Academician Y. Kh. Turakulov, Specialized Hospital

Sabirov U.Y. - Republican Specialized Scientific and Practical Center for Dermatovenereology and Cosmetology Uzbekistan

Mirsaidova U.A. - Republican Specialized Scientific and Practical Center for Dermatovenereology and Cosmetology Uzbekistan

Resume

Background. The skin serves as a visible window to systemic endocrine disorders, with dermatologic manifestations often preceding laboratory abnormalities. This review explores the prevalence and clinical significance of cutaneous signs in endocrine diseases. Materials and Methods. A systematic literature review was conducted using PubMed, Web of Science, and local databases (2010–2024) to analyze epidemiological data and diagnostic pathways. Results. Key findings include: (1) 30–50% of polycystic ovary syndrome (PCOS) patients present with hirsutism/acne, (2) acanthosis nigricans is a marker of insulin resistance in 60–80% of cases, (3) thyroid dermopathy (e.g., pretibial myxedema) occurs in 1–5% of Graves’ disease patients. Conclusion. Dermatologic evaluation can expedite endocrine diagnosis, particularly in resource-limited settings. Interdisciplinary collaboration is essential for optimal patient management

Keywords: endocrine dermatology, cutaneous markers, insulin resistance, hirsutism, thyroid dermopathy

First page

578

Last page

583

For citation:Khalimova Z.Y., Sabirov U.Y., Mirsaidova U.A. - ENDOCRINE DYSFUNCTIONS AND DERMATOLOGIC SIGNS: EPIDEMIOLOGY AND DIFFERENTIAL DIAGNOSIS//New Day in Medicine 6(80)2025 578-583 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Ahmed, S. L., & El-Komy, M. H. (2022). Cutaneous manifestations of endocrine disorders. Clinics in Dermatology, 40(3), 321-329. https://doi.org/10.1016/j.clindermatol.2022.03.001
  2. American Diabetes Association. (2023). Standards of medical care in diabetes—2023. Diabetes Care, 46(Supplement_1), S1-S291.
  3. Azimova, N. A., et al. (2021). Prevalence of PCOS in Uzbek women. Central Asian Journal of Endocrinology, 7(2), 45-52.
  4. Bito, T., & Nishida, E. (2020). Thyroid dermopathy and acropachy. Journal of Clinical Endocrinology & Metabolism, 105(8), e3040-e3045.
  5. Brown, J., et al. (2022). Insulin resistance and skin tags. Diabetes & Metabolic Syndrome, 16(1), 102381.
  6. Chen, W., & Thiboutot, D. (2021). Androgen regulation of sebaceous glands. Dermatology, 237(2), 236-244.
  7. Daudén, E., et al. (2020). Necrobiosis lipoidica. Journal of the European Academy of Dermatology, 34(5), 927-935.
  8. Ebrahimova, G. (2023). Dermatologic signs in Uzbek diabetes patients. Uzbek Medical Journal, 45(3), 78-85.
  9. Ferriman, D., & Gallwey, J. D. (1961). Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology, 21(11), 1440-1447. (Classic reference)
  10. Goodarzi, M. O., et al. (2021). Polycystic ovary syndrome. Nature Reviews Disease Primers, 7(1), 1-18.

    file

    download